Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Thyroid Neoplasms × fosbretabulin × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Head and Neck Neoplasms 1

Interventions

Iodine-131 3 Thyrotropin Alfa 2 vandetanib 1 lenvatinib 1 fosbretabulin 1 combretastatin 1 cabozantinib 1 Thyroidectomy 1 Sorafenib 1 Ropivacaine 1 Radiotherapy 1 Paclitaxel 1 Neck Dissection 1 Metformin 1 Epinephrine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01701349 2014-05-01

FACT2

Mateon Therapeutics

Phase 3 Withdrawn

EndocrineHead & Neck

Head and Neck Neoplasms, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡